Decreased ornithine decarboxylase activity in the kidneys of Dahl salt-sensitive rats

Hypertension Research

Volumn 25, Issue 5, 2002, Pages 787-795

  Hayashi, Takeshi ^a   Tsujino, Takeshi ^a   Iwata, Sachiyo ^a   Nonaka, Hidemi ^a   Emoto, Noriaki ^a   Yano, Yoshihisa ^a   Otani, Shuzo ^a   Hayashi, Yoshitake ^a   Itoh, Hiroshi ^a   Yokoyama, Mitsuhiro ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dahl rat; Kidney; Ornithine decarboxylase; Polyamine; Salt sensitive hypertension

Indexed keywords

ANTIZYME; EFLORNITHINE; MESSENGER RNA; ORNITHINE DECARBOXYLASE; ORNITHINE DECARBOXYLASE INHIBITOR; POLYAMINE DERIVATIVE; PROTEIN INHIBITOR; PUTRESCINE; SODIUM CHLORIDE; SPERMIDINE; SPERMINE; POLYAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DOWN REGULATION; ENZYME ACTIVITY; FEEDING; HYPERTENSION; KIDNEY; MALE; NONHUMAN; POLYAMINE SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SENSITIVITY ANALYSIS; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; DAHL SALT SENSITIVE RAT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART RATE; METABOLISM; ORGAN SIZE; PATHOLOGY; RENOVASCULAR HYPERTENSION; URINE;

ANIMALS; BLOOD PRESSURE; BODY WEIGHT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART RATE; HYPERTENSION, RENAL; KIDNEY; MALE; ORGAN SIZE; ORNITHINE DECARBOXYLASE; POLYAMINES; RATS; RATS, INBRED DAHL;

EID: 0036748145     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.25.787     Document Type: Article

References (36)

1. Tabor CW, Tabor H: Polyamines. Annu Rev Biochem 1984; 53: 749-790.
2. Jänne J, Alhonen L, Leinonen P: Polyamines: from molecular biology to clinical applications. Ann Med 1991; 23: 241-259.
3. Heby O: Role of polyamines in the control of cell proliferation and differentiation. Differentiation 1981; 19: 1-20.
4. Hayashi S: Multiple mechanisms for the regulation of mammalian ornithine decarboxylase, in Hayashi S (ed): Ornithine decarboxylase: Biology, Enzymology and Molecular Genetics. New York, Pergamon, 1980, pp 81-107.
5. Matsufuji S, Matsufuji T, Miyazaki Y, et al: Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell 1995; 80: 51-60.
6. Coffino P: Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2001; 2: 188-194.
7. Murakami Y, Matsufuji S, Kameji T, et al: Ornithine decarboxylase is degraded by 26S proteasome without ubiquitination. Nature 1992; 360: 597-599.
8. Pedersen SB, Flyvbjerg A, Grønbaek H, Richelsen B: Increased ornithine decarboxylase activity in kidneys undergoing hypertrophy in experimental diabetes. Mol Cell Endocrinol 1992; 86: 67-72.
9. Austin HA III, Goldin H, Gaydos D, Preuss HG: Polyamine metabolism in compensatory renal growth. Kidney Int 1983; 23: 581-587.
10. Koibuchi N, Matsuzaki S, Ma HT, Sakai M, Yamaoka S: Induction of ornithine decarboxylase immunoreactivity in the male mouse kidney following testosterone treatment: an axial heterogeneity in the proximal tubule. J Endocrinol 1993; 136: 85-89.
11. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V: Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes. J Clin Invest 2001; 107: 217-224.
12. Tovar A, Sánchez-Capelo A, Cremades A, Peñafiel R: An evaluation of the role of polyamines in different models of kidney hypertrophy in mice. Kidney Int 1995; 48: 731-737.
13. Soltis EE, Newman PS, Olson JW: Eflornithine treatment in SHR: potential role of vascular polyamines and ornithine decarboxylase in hypertension. Clin Exp Hypertens 1994; 16: 595-610.
14. Soltis EE, Newman PS, Olson JW: Polyamines, vascular smooth muscle, and deoxycorticosterone acetate-salt hypertension. Hypertension 1991; 18: 85-92.
15. Ibrahim J, Hughes AD, Schachter M, Sever PS: Depletion of resistance vessel polyamines attenuates angiotensin II induced blood pressure rise in rats. Clin Exp Hypertens 1996; 18: 811-830.
16. Kai T, Ishikawa K: Lisinopril reduces left ventricular hypertrophy and cardiac polyamine concentrations without a reduction in left ventricular wall stress in transgenic Tsukuba hypertensive mice. Hypertens Res 2000; 23: 625-63 1.
17. Matsufuji S, Miyazaki Y, Kanamoto R, et al: Analyses of ornithine decarboxylase antizyme mRNA with a cDNA cloned from rat liver. J Biochem 1990; 108: 365-371.
18. Otani S, Matsui I, Nakajima S, Masutani M, Mizoguchi Y, Morisawa S: Induction of ornithine decarboxylase in guinea pig lymphocytes by the divalent cation ionophore A23187 and phytohemagglutinin. J Biochem 1980; 88: 77-85.
19. Kubota S, Okada M, Imahori K, Ohsawa N: A new simple enzymatic assay method for urinary polyamines in humans. Cancer Res 1983; 43: 2363-2367.
20. Lipke DW, Newman PS, Toliq S, Aziz SM, Soltis EE: Eflornithine alters changes in vascular responsiveness associated with coarctation hypertension. Clin Exp Hypertens 1997; 19: 297-312.
21. +-dependent active type and erythrocyte/HepG2-type glucose transporters in rat kidney: immunofluorescence and immunogold study. J Histochem Cytochem 1991; 39: 287-298.
22. +/glucose symporter expression in LLC-PK1 cells. J Cell Physiol 1993; 154: 238-247.
23. Kitada M, Igarashi K, Hirose S, Kitagawa H: Inhibition by polyamines of lipid peroxide formation in rat liver microsomes. Biochem Biophys Res Commun 1979; 87: 388-394.
24. Ha HC, Sirisoma NS, Kuppusamy P, Zweier JL, Woster PM, Casero RA Jr: The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci USA 1998; 95: 11140-11145.
25. Bors W, Langebartels C, Michel C, Sandermann H Jr: Polyamines as radical scavengers and protectants against ozone damage. Phytochemistry 1989; 28:1589-1595.
26. Løvaas E: Hypothesis: spermine may be an important epidermal antioxidant. Med Hypotheses 1995; 45: 59-67.
27. Lacy F, O'Connor DT, Schmid-Schonbein GW: Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998; 16: 291-303.
28. Russo C, Olivieri O, Girelli D, et al: Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998; 16: 1267-1271.
29. Swei A, Lacy F, DeLano FA, Schmid-Schönbein GW: Oxidative stress in the Dahl hypertensive rat. Hypertension 1997; 30: 1628-1633.
30. Gonick HC, Cohen AH, Ren Q, et al: Effect of 2,3-dimercaptosuccinic acid on nephrosclerosis in the Dahl rat. I. Role of reactive oxygen species. Kidney Int 1996; 50: 1572-1581.
31. Iwata S, Tsujino T, Ikeda Y, et al: Decreased expression of arginase II in the kidney of Dahl salt-sensitive rat. Hypertens Res 2002; 25: 411-418.
32. Murakami Y, Matsufuji S, Hayashi S, Tanahashi N, Tanaka K: ATP-dependent inactivation and sequestration of ornithine decarboxylase by the 26S proteasome are prerequisites for degradation. Mol Cell Biol 1999; 19: 7216-7227.
33. Satriano J, Matsufuji S, Murakami Y, et al: Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. J Biol Chem 1998; 273: 15313-15316.
34. Babal P, Ruchko M, Campbell CC, et al: Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells. J Pharmacol Exp Ther 2001; 296: 372-377.
35. Morrissey J, McCracken R, Ishidoya S, Klahr S: Partial cloning and characterization of an arginine decarboxylase in the kidney. Kidney Int 1995; 47: 1458-1461.
36. Wood PA, Hamm DA, Chen PY, Sanders PW: Studies of arginine metabolism and salt sensitivity in the Dahl/Rapp models of hypertension. Mol Genet Metab 1998; 64: 80-83.